Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2022 Benefit Year
The purpose of this memorandum is to announce the continuation of two reporting initiatives
for the 2022 benefit year that support CMS’ efforts to improve the accuracy of sponsors’ PDE
data. The PDE Reports and PDE Analysis initiatives are both facilitated by CMS’ contractor,
Acumen, LLC, and participating sponsors will continue to use the secure PDE Reports and
PDE Analysis web portals. The remainder of this memorandum provides overviews of the PDE
Reports and PDE Analysis initiatives and describes the actions expected from participating
sponsors. Attachment A provides details of the PDE Reports initiative. Attachment B supplies
further information on the PDE Analysis process. Attachment C explains the steps that sponsors
must complete to authorize users for the PDE Reports and PDE Analysis web portals.
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 29, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.